HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.

AbstractBACKGROUND:
The inflammatory marker long pentraxin 3 (PTX3) has been shown to be a strong predictor of 30-day and one-year mortality after acute myocardial infarction. The aim of this study was to evaluate the kinetic profile of PTX3 and its relationship with interleukin 6 (IL-6), high-sensitive C-reactive protein (hs-CRP) and infarct size.
METHODS:
PTX3, IL-6 and hs-CRP were measured at predefined time points, at baseline (before percutaneous coronary intervention (PCI)), at 12 and 72 hours after PCI in 161 patients with first-time ST elevation myocardial infarction (STEMI).
RESULTS:
PTX3 and IL-6 levels increased in the early phase, followed by a gradual decrease between 12 and 72 hours. There were statistically significant correlations between PTX3 and IL-6 in general, for all time points and for changes over time (0-72 hours). In a linear mixed model, PTX3 predicted IL-6 (p < 0.001). PTX3 is also correlated with hs-CRP in general, and at each time point post PCI, except at baseline. PTX3, IL-6 and hs-CRP were all significantly correlated with infarct size in general, and at the peak time point for maximum troponin I. In addition, there was a modest correlation between IL-6 levels at baseline and infarct size at 72 hours after PCI (ρ = 0.23, p = 0.006).
CONCLUSIONS:
PTX3 had a similar kinetic profile to IL-6, with an early increase and decline, and was statistically significantly correlated with markers of infarct size in STEMI patients post primary PCI. Baseline levels of IL-6 only predicted infarct size at 72 hours post PCI.
AuthorsNoreen Butt, L K Bache-Mathiesen, A Ushakova, J E Nordrehaug, S E Jensen, P S Munk, N Danchin, J L Dubois-Rande, H S Hansen, F Paganelli, P Le Corvoisier, H Firat, D Erlinge, D Atar, A I Larsen
JournalEuropean heart journal. Acute cardiovascular care (Eur Heart J Acute Cardiovasc Care) Vol. 9 Issue 4 Pg. 302-312 (Jun 2020) ISSN: 2048-8734 [Electronic] England
PMID32403934 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Biomarkers
  • Interleukin-6
  • Serum Amyloid P-Component
  • Troponin I
  • Troponin T
  • PTX3 protein
  • C-Reactive Protein
Topics
  • Aged
  • Biomarkers (blood)
  • C-Reactive Protein (metabolism)
  • Female
  • Follow-Up Studies
  • Humans
  • Interleukin-6 (blood)
  • Male
  • Middle Aged
  • Myocardium (metabolism)
  • Percutaneous Coronary Intervention
  • Retrospective Studies
  • ST Elevation Myocardial Infarction (blood, diagnosis, surgery)
  • Serum Amyloid P-Component (metabolism)
  • Severity of Illness Index
  • Troponin I (blood)
  • Troponin T (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: